Is a wound consisting primarily of exposed bone with minimal surrounding soft tissue a poor candidate for placement of a biologic matrix?

You are correct—a wound consisting primarily of exposed bone with minimal surrounding soft tissue is generally a poor candidate for biologic matrix placement alone.

Critical Wound Bed Requirements

Biologic matrices require adequate vascular supply and viable soft tissue to integrate successfully. When bone exposure dominates the wound with minimal surrounding tissue, several critical factors compromise biologic matrix success:

Blood Supply is Paramount

The most important determinant is whether the bone has intact periosteum or is completely denuded (deperiosted):

• Intact periosteum with minimal soft tissue: Biologic matrices can potentially work, as the periosteum provides vascular supply for matrix integration 1
• Deperiosted bone (periosteal stripping): This is associated with significantly higher complication rates—up to 40% versus 21.8% in wounds with intact periosteum (P = 0.005) 1

Wounds with combined bone and tendon exposure plus periosteal stripping have complication rates exceeding 57% 1, making them particularly poor candidates for biologic matrix placement.

Why Minimal Soft Tissue Matters

Biologic matrices function by:

1. Providing a scaffold for host fibroblast infiltration
2. Promoting angiogenesis and neovascularization
3. Facilitating extracellular matrix remodeling 1, 2

Without adequate surrounding viable tissue, there is insufficient cellular infiltration and vascular ingrowth to support matrix integration. The matrix essentially has nowhere to "anchor" biologically.

Evidence-Based Outcomes

A systematic review of 208 patients demonstrated that wounds with vascular compromise (periosteal stripping or denuded structures) had significantly worse outcomes 1. Specifically:

• Deperiosted bone defects achieved successful one-stage coverage in only 2 of 6 patients (33% success rate) 3
• Multiple patients required repeat applications or secondary procedures
• Chronic wounds independently increased complication risk 4-fold (P = 0.013) 1

Clinical Decision Algorithm

For wounds with predominantly exposed bone and minimal soft tissue:

1. Assess periosteum status first:

   • If periosteum intact → Biologic matrix may be considered with close monitoring
   • If deperiosted → Biologic matrix alone is high-risk; consider alternative approaches

2. Evaluate surrounding tissue viability:

   • Minimal viable soft tissue (<20% of wound bed) → Poor candidate
   • Adequate soft tissue rim with vascular supply → Reasonable candidate

3. Consider wound chronicity:

   • Acute wounds → Better outcomes
   • Chronic wounds → 4-fold increased complication risk 1

4. Alternative strategies for poor candidates:

   • Negative pressure wound therapy (NPWT) to promote granulation tissue formation first 4, 2
   • Two-stage approach: NPWT followed by delayed biologic matrix application once granulation tissue develops
   • Traditional flap reconstruction for definitive coverage 5
   • Bone perforation/drilling to stimulate bleeding and vascular ingrowth before matrix placement 6

Common Pitfalls to Avoid

Do not place biologic matrices on:

• Completely deperiosted bone without first establishing vascular access through bone perforation
• Necrotic or infected bone without adequate debridement 5
• Wounds with inadequate soft tissue coverage where primary closure cannot be achieved 6

The key principle: Biologic matrices are adjuncts that enhance healing in viable tissue beds—they cannot substitute for absent vascularity or create tissue where none exists. In wounds with predominantly exposed bone and minimal soft tissue, focus first on establishing a vascular bed through NPWT, bone perforation, or staged procedures before considering biologic matrix placement 1, 2.

For lower extremity wounds with these characteristics, complication rates are particularly elevated compared to upper extremity (odds ratio 0.295, P = 0.008) 1, further supporting cautious patient selection.